Ricinus Communis (Castor) Seed Oil, Octocrylene, Ethylhexyl Methoxycinnamate, Hydrogenated Soy Polyglycerides (and) C15-23 Alkanes, Sorbitan Olivate, Hydrogenated Polyisobutene, Butyrospermum Parkii (Shea) Butter, Color, Ascorbyl Palmitate, Tocopheryl Acetate, Theobroma Cacao (Cocoa) Seed Butter, Persea Gratissima (Avocado) Oil, Caprylic/Capric Triglyceride (and) Polyurethane-79, Flavour, Pentaerythrityl Tetra-Di-T-Butyl Hydroxyhydrocinnamate, Sucralose
Theoretical synergy: three pathways working together Triple-pathway hypothesis: Why it might work: Non-overlapping receptor pathways Complementary not redundant Multiple appetite suppression mechanisms Enhanced metabolic effects Potential for greater weight loss than either alone Comparison to proven combinations: CagriSema (semaglutide + cagrilintide): 15-25% proven Tirzepatide alone: 15-22% proven Theoretical tirzepatide + cagrilintide: 20-30% unproven The critical problem: no clinical data What we DON'T know: Is the combination safe
Common side effects are mild and include injection site reactions (redness, irritation), temporary water retention, tingling or numbness in the extremities, mild headache, and occasional flushing
It is possible to get a prescription for GLP-1 online, such as through MEDvidi, but you must first attend a virtual appointment to discuss your health status and medical history